GenePOC Receives CE Mark for Drug-Resistant Bacteria Test

Jan

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb

Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Menu

GenePOC Receives CE Mark for Drug-Resistant Bacteria Test

To read the full story....

Breaking News

Abbott Warns Customers to Discontinue Use of Certain Blood Analysis Cartridges

Agilent, UK Academic Researchers Investigate Risk Factors for Eczema

In Brief This Week: PerkinElmer, ArcherDX, Caris, and More

GenDx Gets CE Mark for HLA Typing Products

Lab Owner in $130M Genetic Testing Fraud Case Pleads Guilty

Color Raises $75M to Scale Infrastructure

Featured White Papers

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Development of a Novel Multiplex Assay: A Partnership Case Study

What's Popular?

JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics

Color Raises $75M to Scale Infrastructure

JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio

JP Morgan Healthcare Day 4: Biocartis, Oxford Immunotec

Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing

Sponsorships